Correlation Between Aclaris Therapeutics and Psychemedics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Psychemedics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Psychemedics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Psychemedics, you can compare the effects of market volatilities on Aclaris Therapeutics and Psychemedics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Psychemedics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Psychemedics.

Diversification Opportunities for Aclaris Therapeutics and Psychemedics

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aclaris and Psychemedics is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Psychemedics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psychemedics and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Psychemedics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psychemedics has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Psychemedics go up and down completely randomly.

Pair Corralation between Aclaris Therapeutics and Psychemedics

Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 36.53 times more return on investment than Psychemedics. However, Aclaris Therapeutics is 36.53 times more volatile than Psychemedics. It trades about 0.29 of its potential returns per unit of risk. Psychemedics is currently generating about 0.09 per unit of risk. If you would invest  161.00  in Aclaris Therapeutics on August 28, 2024 and sell it today you would earn a total of  202.00  from holding Aclaris Therapeutics or generate 125.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Aclaris Therapeutics  vs.  Psychemedics

 Performance 
       Timeline  
Aclaris Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Psychemedics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Psychemedics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, Psychemedics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Aclaris Therapeutics and Psychemedics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aclaris Therapeutics and Psychemedics

The main advantage of trading using opposite Aclaris Therapeutics and Psychemedics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Psychemedics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psychemedics will offset losses from the drop in Psychemedics' long position.
The idea behind Aclaris Therapeutics and Psychemedics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world